Marksans Pharma: USFDA Approves Its Benzonatate Capsules USP 100 Mg And 200 Mg.

Baazar Style Retail: Closes One Store In Brahmapur, Odisha, Bringing Total Stores To 262

ITC: Acquires Majority Board Nomination Rights In Sproutlife Foods, Making It A Subsidiary From April 1, 2026.

Aeroflex Industries: FY27 Impact - Phase 1 Adds ₹120 Crore Incremental Revenue (Full Fy27 At 6,000 Units); Full Ramp Adds Another ₹270 Cr (To ₹450 Crore Total), But Management Guides ₹300-350 Cr At Sustainable Peak Utilization.

ATUL AUTO: MARCH TOTAL SALES UNITS 4,212 VS 3,693 UNITS (YOY)

AeroFlex Industries: Increases Liquid Cooling “SFN Skid Assembly” Capacity From 2,000 To 6,000 Pieces Per Year, With Production Starting April 1, 2026, And Further Expansion To 15,000 Pieces By June/July 2026.

Lloyds Metals And Energy: Says FY26 Iron Ore Output Reached 21.96 Million Tonnes, Forecasting 26 Million Tonnes For FY27 || Q4 FY26 Volumes Stood At 9.1 Million Tonnes, Representing 529% Yoy Increase.

Lloyds Metals: Achieves Record Iron Ore Production At 21.96 Million Tons, Double FY25 And Up Sharply Year Over Year

Lloyds Metals And Energy: DRI Production Jumps 57% YoY To 484K Tonnes, Pellet Output Hits 3.03 Million Tonnes At Full Capacity Utilisation.

Intellect Design Arena: Company Announces Deal With Major Logistics Leader To Deploy Purple Fabric Accounts Payable Solution, Moving To AI Automation For Better Efficiency And Scalability

Paradeep Phosphate: Ebitda Uplift - Contributes To Fy27 Incremental Ebitda Of ~₹350 Crore From Mangalore Expansions

Bharat Electronics: Records ₹26,750 Crore Turnover in FY 2025-26, Up 16.2% From ₹23,024 Crore; Slightly Below ₹27,000 Crore Guidance.

Petronet LNG: Company Starts Dahej LNG Terminal Expansion From 17.5 MMTPA To 22.5 MMTPA, Completed On 31 March 2026.

Paradeep Phosphates: Commissions 300 TPD Plant, Expands Capacity To 400 TPD And Invests ₹240 Cr In Backward Integration, Using Process Waste Heat To Generate ~1,05,000 Tonnes Of High-Pressure Steam Annually.

HYUNDAI MOTOR: MARCH TOTAL SALES 69,004 UNITS VS 67,320 UNITS (YOY); EST 64,100

GAUDIUM IVF AND WOMEN HEALTH: Q3 EBITDA 66M RUPEES VS 57M (YOY) || Q3 EBITDA MARGIN 26.72% VS 39.22% (YOY)

GAUDIUM IVF AND WOMEN HEALTH: Q3 CONS NET PROFIT 36M RUPEES VS 34M (YOY) || Q3 REVENUE 245M RUPEES VS 144M (YOY)